151 related articles for article (PubMed ID: 10102674)
1. Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice.
Kowalski J
Neuropeptides; 1998 Aug; 32(4):301-6. PubMed ID: 10102674
[TBL] [Abstract][Full Text] [Related]
2. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
Yuan CS; Foss JF
Neuropharmacology; 1999 Mar; 38(3):425-32. PubMed ID: 10219980
[TBL] [Abstract][Full Text] [Related]
3. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists.
Morgan EL
J Neuroimmunol; 1996 Mar; 65(1):21-30. PubMed ID: 8642060
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
6. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Lohmann AB; Welch SP
Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
[TBL] [Abstract][Full Text] [Related]
7. Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study.
Takita K; Herlenius EA; Lindahl SG; Yamamoto Y
Brain Res; 1997 Dec; 778(1):233-41. PubMed ID: 9462896
[TBL] [Abstract][Full Text] [Related]
8. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
9. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
[TBL] [Abstract][Full Text] [Related]
10. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
Evans RG; Ludbrook J; Van Leeuwen AF
J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
[TBL] [Abstract][Full Text] [Related]
11. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ.
Mogil JS; Grisel JE; Zhangs G; Belknap JK; Grandy DK
Neurosci Lett; 1996 Aug; 214(2-3):131-4. PubMed ID: 8878101
[TBL] [Abstract][Full Text] [Related]
12. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices.
Schlösser B; Kudernatsch MB; Sutor B; ten Bruggencate G
Neurosci Lett; 1995 May; 191(1-2):126-30. PubMed ID: 7659278
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
14. Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum.
Nishiwaki H; Saitoh N; Nishio H; Takeuchi T; Hata F
Jpn J Pharmacol; 1998 Aug; 77(4):279-86. PubMed ID: 9749928
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
16. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.
Nelson CJ; Schneider GM; Lysle DT
Brain Behav Immun; 2000 Sep; 14(3):170-84. PubMed ID: 10970678
[TBL] [Abstract][Full Text] [Related]
17. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
Bot G; Chahl LA
Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
[TBL] [Abstract][Full Text] [Related]
18. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes.
Walsh JP; Clarke IJ
Endocrinology; 1996 Sep; 137(9):3640-8. PubMed ID: 8756528
[TBL] [Abstract][Full Text] [Related]
19. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
20. Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses.
Rahim RT; Meissler JJ; Cowan A; Rogers TJ; Geller EB; Gaughan J; Adler MW; Eisenstein TK
Int Immunopharmacol; 2001 Oct; 1(11):2001-9. PubMed ID: 11606031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
